Science Explorer Back to mapMap
Discussion
Researcher · Harbin Medical University · China

Jianhua Shi

Jianhua Shi publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-5351-406X OpenAlex
World rank
#131,927
of 7,710,434 ranked researchers
Rank in China
#12,163
of 978,568
Works
142
Citations
6.7k
Citations per work
47.0
h-index
31
i10-index 65Top 11% in Oncology
Jianhua Shi

What does Jianhua Shi research?

Jianhua Shi's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 109 works · 76.7% of their workMedicine: 109 works · 76.7% of their workOncology: 48 works · 34.0% of their workPulmonary and Respiratory Medicine: 41 works · 29.2% of their workSurgery: 10 works · 7.2% of their workHepatology: 5 works · 3.4% of their workEpidemiology: 4 works · 2.9% of their workEverything else: 26 works · 18.2% of their workLife Sciences: 7 works · 5.1% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 5.1% of their workMolecular Biology: 7 works · 5.1% of their workTHEIR WORKJianhua Shi142works
Life Sciences5%Health Sciences77%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10976.7%
  2. Everything else2618.2%
    1. Biochemistry, Genetics and Molecular Biology75.1%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine29% of their works
  3. 3Surgery7% of their works
  4. 4Molecular Biology5% of their works
  5. 5Hepatology3% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Jianhua Shi's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and Tumor Microenvironment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy1273 topics
  2. Clinical Trials1182 topics
  3. Chemotherapy984 topics
  4. ALK Inhibitors671 topic
  5. EGFR Mutations671 topic
  6. Genomic Profiles511 topic
  7. Small-Cell Lung Cancer511 topic
  8. Tumor Microenvironment452 topics
  9. Immune Checkpoint Blockade351 topic
  10. PD-1 and PD-L1351 topic
  11. Adjuvant Therapy302 topics
  12. CT Screening181 topic
  13. Lung Cancer181 topic
  14. Cetuximab171 topic
  15. KRAS Mutations171 topic
  16. Endoscopic Resection121 topic
  17. Gastric Cancer121 topic
  18. Fibroblast Activation Protein101 topic
  19. Immunosuppression101 topic
  20. Cancer Genomics91 topic
  21. Mutational Signatures91 topic

Where does Jianhua Shi work?

Jianhua Shi's main affiliation in the publication record is Harbin Medical University, China.

How many publications and citations does Jianhua Shi have?

OpenAlex counts 142 works and 6,668 citations for Jianhua Shi, an h-index of 31, ranking #131,927 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jianhua Shi

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jianhua Shi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.